Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults with Stage I-III Breast Cancer Who Have Completed Curative Treatment
Not Applicable
Recruiting
- Conditions
- Anatomic Stage II Breast Cancer AJCC V8Anatomic Stage I Breast Cancer AJCC V8Anatomic Stage III Breast Cancer AJCC V8
- Interventions
- Other: Comprehensive Geriatric AssessmentBehavioral: Health EducationOther: Medical Device Usage and EvaluationOther: Supportive Care
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05928325
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
A Study of Response Adapted Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Marginal Zone Lymphoma
Phase 2
Recruiting
- Conditions
- Lymphoma
- Interventions
- Radiation: Ultra Low Dose 4 Gy Radiation
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT05929612
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer
Phase 1
Recruiting
- Conditions
- Ovarian CancerAdenocarcinomaPancreatic Cancer
- Interventions
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2025-04-27
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 51
- Registration Number
- NCT05922930
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma
Phase 2
Recruiting
- Conditions
- Hodgkin Lymphoma
- Interventions
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 25
- Registration Number
- NCT05922904
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Harmony & Health: A Culturally Adapted Mindbody Intervention to Reduce Sitting Time and Improve Psychosocial Wellbeing in Black Adults
Not Applicable
Recruiting
- Conditions
- Psychosocial
- Interventions
- Behavioral: Harmony & Health program
- First Posted Date
- 2023-06-28
- Last Posted Date
- 2025-03-26
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 250
- Registration Number
- NCT05922943
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
Development of Brief Positive Affect Treatment (PAT) for Caregivers of Patients With Advanced Cancer
Not yet recruiting
- Conditions
- Cancer
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 150
- Registration Number
- NCT05904782
An Evaluation of the Implementation of the Care and Monitoring at Home Program- A New Paradigm for Acute Care Management of Cancer Patients
Suspended
- Conditions
- Cancer
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2025-02-18
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT05904899
- Locations
- 🇺🇸
MD Anderson Cancer Center, Houston, Texas, United States
Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME)
Phase 2
Withdrawn
- Conditions
- Colorectal CancerColon CancerRectum Cancer
- Interventions
- First Posted Date
- 2023-06-12
- Last Posted Date
- 2024-04-29
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT05900648
Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers
- First Posted Date
- 2023-06-01
- Last Posted Date
- 2025-04-08
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05884320
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
HEALTH4CLL2: A Randomized Waitlist Control Trial of Behavioral Interventions in Patients With Chronic Lymphocytic Leukemia
Not Applicable
Recruiting
- Conditions
- Chronic Lymphocytic Leukemia
- Interventions
- Behavioral: QuestionnairesOther: Fit Bit
- First Posted Date
- 2023-05-30
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT05879133
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath